Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1986-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00160A035PMID 3761319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and Sch-12679, in rats trained with LSD as a discriminative stimulus

  2004cited by this paper
• A protocol for the evaluation of new psychoactive drugs in man.

  1986cited by this paper
• Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane.

  1984cited by this paper
• Further investigation of the discriminative stimulus properties of MDA.

  1984cited by this paper
• Depriving rats of food: A reappraisal of two techniques.

  1983cited by this paper
• Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes.

  1982cited by this paper
• A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.

  1982cited by this paper
• Discriminative stimulus properties of MDA analogs.

  1982cited by this paper
• Behavioral properties of psychoactive phenylisopropylamines in rats.

  1981cited by this paper
• Phenylakylamines with potential psychotherapeutic utility. 1. 2-Amino-1-(2,5-dimethoxy-4-methylphenyl)butane.

  1976cited by this paper
• Experimental methods for the study of state-dependent learning.

  1974cited by this paper
• Stereospecific requirements for hallucinogenesis

  1973cited by this paper
• Asymmetric synthesis of psychotomimetic phenylisopropylamines.

  1973cited by this paper
• Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct to psychotherapy.

  1967cited by this paper
• Psychotomimetic agents related to mescaline

  1963cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Psychedelics and the treatment of eating disorders: considerations for future research and practice

  2024cites this paper
• Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile “the great entactogen—empathogen debate”

  2024cites this paper
• CATHINONES AND VIAGRA IN CHEMSEX: AN AUTOETHNOGRAPHY OF TOUCH, MASCULINITIES AND AESTHETICS

  2024cites this paper
• A simple polyarginine membrane electrochemical sensor for the determination of MDMA and MDA.

  2024cites this paper
• Psychedelic intimacy: Altered states of consciousness in romantic relationships

  2024cites this paper
• If Everything Is Psychedelic, Then Nothing Is: A Response to O'Donnell et al. and Lepow et al.

  2023cites this paper
• Swim in the Chiral Pool: MDMA and MDA Enantiomers from Alanine-Derived Precursors

  2023cites this paper
• Therapeutic mechanisms of psychedelics and entactogens

  2023cites this paper
• α-Ethyltryptamine: A Ratiocinatory Review of a Forgotten Antidepressant.

  2023cites this paper
• An Update on the Implications of New Psychoactive Substances in Public Health

  2022influential citation
• Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.

  2022cites this paper
• Entactogens: How the Name for a Novel Class of Psychoactive Agents Originated

  2022cites this paper
• MDMA – hopes and fears associated with therapeutic use in mental disorders

  2020cites this paper
• Evaluation of immunoassays for the determination of MDMA and cannabinoids in urine samples

  2020influential citation
• Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy

  2020influential citation
• Serotonin and serotonin receptors in hallucinogen action

  2020cites this paper
• Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA (“Ecstasy”) in Rats and Preserves Affinity for the Serotonin Transporter (SERT)

  2019cites this paper
• Roadmaps to regulation : MDMA

  2019cites this paper
• Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.

  2018cites this paper
• Synthetic Aminoindanes: A Summary of Existing Knowledge

  2017cites this paper
• Hydrothermally synthesized zinc oxide nanorods incorporated on lab-on-paper device for electrochemical detection of recreational drug

  2017cites this paper
• Constructing the ecstasy of MDMA from its component mental organs: Proposing the primer/probe method.

  2016cites this paper
• Designer phenethylamines routinely found in human urine: 2-ethylamino-1-phenylbutane and 2-amino-1-phenylbutane.

  2014cites this paper
• Identification of an acetal derivative of the piperonyl methyl ketone in tablets seized for suspected drug trafficking

  2014cites this paper
• UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset.

  2014cites this paper
• Looking for prosocial genes: ITRAQ analysis of proteins involved in MDMA-induced sociability in mice.

  2014cites this paper
• Molecular basis of the selective binding of MDMA enantiomers to the alpha4beta2 nicotinic receptor subtype: synthesis, pharmacological evaluation and mechanistic studies.

  2014cites this paper
• Effects of MDMA on the Human Nervous System

  2014cites this paper
• MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology

  2013influential citation
• Microglial and astroglial activation by 3,4‐methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility

  2013cites this paper
• Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs.

  2013cites this paper
• Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats.

  2012cites this paper
• Fluorine in psychedelic phenethylamines.

  2012cites this paper
• Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine (‘ecstasy’) through iterative chemical redesign: mechanisms and pathways to cell death

  2012cites this paper
• Behavioral profiles in rats distinguish among "ecstasy," methamphetamine and 2,5-dimethoxy-4-iodoamphetamine: Mixed effects for "ecstasy" analogues.

  2010cites this paper
• Neurobehavioral Toxicology of Substances of Abuse

  2010cites this paper
• Toxicological Methods for Tracing Drug Abuse: Chromatographic, Spectroscopic and Biological Characterisation of Ecstasy Derivatives

  2010cites this paper
• Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity

  2010cites this paper
• Comparison of GC-MS and GC-IRD methods for the differentiation of methamphetamine and regioisomeric substances.

  2009cites this paper
• Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.

  2009cites this paper
• Enantiomers of Methylenedioxy Designer Drugs The Role of Cytochrome P 450 s and Catechol-O-methyltransferase in Their Metabolism

  2009cites this paper
• Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomers.

  2009cites this paper
• GC and mass spectral studies on acylated side chain regioisomers of 3-methoxy-4-methyl-phenethylamine and 4-methoxy-3-methyl-phenethylamine.

  2009cites this paper
• GC-MS and GC-IRD Studies on Ethoxyphenethylamines Related to MDEA, MDMMA and MDBD

  2009cites this paper
• 1 Medicinal Chemistry and Structure-Activity Relationships

  2009cites this paper
• Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomers.

  2009cites this paper
• GC-MS studies on acylated derivatives of 3-methoxy-4-methyl- and 4-methoxy-3-methyl-phenethylamines: regioisomers related to 3,4-MDMA.

  2008cites this paper
• MDMA Induces EPSP–Spike Potentiation in Rat Ventral Hippocampus In Vitro Via Serotonin and Noradrenaline Release and Coactivation of 5-HT4 and β1 Receptors

  2008cites this paper
• GC-MS analysis of ring and side chain regioisomers of ethoxyphenethylamines.

  2008cites this paper
• GC-MS studies on the regioisomeric methoxy-methyl-phenethylamines related to MDEA, MDMMA, and MBDB.

  2008cites this paper
• Human hallucinogen research: guidelines for safety

  2008cites this paper
• Ru3(CO)12-catalyzed reactions of catechols with alkynes: an atom-economic process for the synthesis of 2,2-disubstituted 1,3-benzodioxoles from the double addition of the O-H bond across a triple bond.

  2008cites this paper
• Correlation between the synthetic origin of methamphetamine samples and their 15N and 13C stable isotope ratios.

  2007cites this paper
• GC-MS analysis of acylated derivatives of the side-chain regioisomers of 4-methoxy-3-methyl-phenethylamines related to methylenedioxymethamphetamine.

  2007cites this paper
• Comparative potencies of 3,4‐methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5‐HT transport in mammalian cell lines

  2007cites this paper
• Electrochemical and spectroscopic characterisation of amphetamine-like drugs: application to the screening of 3,4-methylenedioxymethamphetamine (MDMA) and its synthetic precursors.

  2007cites this paper
• α1-Adrenergic Receptors Mediate the Locomotor Response to Systemic Administration of (±)-3,4-Methylenedioxymethamphetamine (MDMA) in rats

  2007influential citation
• GC-MS studies on the regioisomeric 2,3- and 3,4-methylenedioxyphenethylamines related to MDEA, MDMMA, and MBDB.

  2007cites this paper
• Hydrazines and azides via the metal-catalyzed hydrohydrazination and hydroazidation of olefins.

  2006cites this paper
• Differential Contributions of Dopamine D1, D2, and D3 Receptors to MDMA-Induced Effects on Locomotor Behavior Patterns in Mice

  2006cites this paper
• Synthesis of Fluoro Analogues of 3,4‐(Methylenedioxy)amphetamine (MDA) and Its Derivatives

  2006cites this paper
• Enantiomerentrennung regioisomerer Methylendioxyamphetamine mittels chiral modifizierter HPLC

  2006cites this paper
• GC-MS analysis of acylated derivatives of the side chain and ring regioisomers of methylenedioxymethamphetamine.

  2005cites this paper
• Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists

  2005cites this paper
• Pharmacological Characterization of Ecstasy Synthesis Byproducts with Recombinant Human Monoamine Transporters

  2005cites this paper
• ANALYSIS OF FORENSIC SAMPLES OF "ECSTASY" TABLETS SEIZED IN NOVI SAD DURING THE 2004 YEAR

  2005cites this paper
• Asian American Youth, the Dance Scene, and Club Drugs

  2005cites this paper
• 3,4-Methylenedioxyamphetamines

  2005cites this paper
• Some pyridine derivatives as "route-specific markers" in 4-methoxyamphetamine (PMA) prepared by the Leuckart Method Studies on the role of the aminating agent in their distribution in the final product.

  2005cites this paper
• II.2.7 3,4-Methylene- dioxyamphetamines

  2005cites this paper
• Increased responsiveness to MDMA in adult rats treated neonatally with MDMA.

  2005cites this paper
• A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA

  2004cites this paper
• MDMA ("Ecstasy") in Tiermodellen des Morbus Parkinson

  2004cites this paper
• Gas chromatographic optimization studies on the side chain and ring regioisomers of methylenedioxymethamphetamine.

  2004cites this paper
• Drug discrimination studies with MDMA and amphetamine

  2004cites this paper
• 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin-reuptake transporter, and monoamine oxidase-B.

  2004cites this paper
• Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?

  2003influential citation
• Chromatographic and spectroscopic methods of identification for the side-chain regioisomers of 3,4-methylenedioxyphenethylamines related to MDEA, MDMMA, and MBDB.

  2003cites this paper
• Arylethylamine psychotropic recreational drugs: a chemical perspective.

  2002cites this paper
• Update on Clandestine Amphetamines and Their Analogues Recently Seen in Japan

  2002cites this paper
• icrodialysis studies on 3 , 4 methylenedioxyamphetamine a related analogues

  2002cites this paper
• Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement

  2002cites this paper
• Behavioral Psychopharmacology of MDMA and MDMA-Like Drugs: A Review of Human and Animal Studies

  2002cites this paper
• Further characterization of the stimulus properties of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5-g]isoquinoline.

  2002cites this paper
• Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites.

  2002cites this paper
• Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats

  2002influential citation
• EJP 53172 5H T 2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits

  2002cites this paper
• Platzpräferenz und Metabolismus von Enantiomeren der Party-Drogen MDMA und MDE bei der Ratte

  2002cites this paper
• Enantiomer analysis of a new street drug, 3,4-methylenedioxy-N-methyl-butanamine, in rat urine.

  2002cites this paper
• PSYCHEDELIC DRUGS

  2002influential citation
• PMMA-stimulus generalization to the optical isomers of MBDB and 3,4-DMA.

  2001cites this paper
• An Exploration of the History and Controversies Surrounding MDMA and MDA

  2001cites this paper
• Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.

  2001cites this paper
• The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity.

  2001cites this paper
• A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone

  2001cites this paper
• Efectos conductuales del MDMA ("éxtasis") en animales de experimentación

  2001cites this paper
• A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone.

  2001cites this paper
• Synthesis of 2,3- and 3,4-methylenedioxyphenylalkylamines and their regioisomeric differentiation by mass spectral analysis using GC-MS-MS.

  2000cites this paper
• N‐methyl‐1‐(1,3‐benzodioxol‐5‐yl)‐2‐butanamine (MBDB): its properties and possible risks

  2000cites this paper
• Serotonin releasers increase prepulse inhibition in serotonin 1B knockout mice

  2000cites this paper